Abdominal sacrocolpopexy 'less effective than desired' for POP
May 14, 2013|ObGyn
Author and Disclosure Information
FROM JAMA
The extended CARE study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Office of Research on Women’s Health at the National Institutes of Health. Dr. Nygaard reported no financial conflicts of interest; some of her associates reported ties to Johnson & Johnson, Key Tech, Pelvalon, Astellas, Pfizer, Warner Chilcott, GlaxoSmithKline, Uromedica, IDEO, Xanodyne, and Intuitive Surgical.
